CherylSwanson

Cheryl Swanson

Six books published--med tech, running a small business, surviving cancer, novels, whatever life throws at me. My latest book is the thriller, "A Mug's Game." I learned stock investing at nineteen, when the economics professor I worked for went on a binge, leaving me with indecipherable notes for his thirty-page stock newsletter. Hmmm...what can I add? Kauai is home, but please don't visit, move here. We need more solid, hard-working folk in paradise. I've owned a software company (Compudontics), given post-doctoral programs for the American Dental Association and Canadian College of Dental Surgeons, consulted with Baylor University Med School, worn a lot of pantyhose...glad those days are over. I spend time traveling to third world countries and giving back these days. I believe in the paradox you can't keep your wealth unless you give it back. In a sense, being charitable is actually selfish, but a spiritually healthy kind of selfishness. Believe it or not, that actually improves your investing!

CherylSwanson’s Activity

Tue Dec 13

NL

Article

CherylSwanson published an article 4:22 PM

Could Gilead Sciences' Game-Changing HIV Pill Solve Its Growth Problem?

Gilead's HIV preventing med is not only groundbreaking, it could be the cure to what ails this stock.

Thu Dec 1

NL

Article

CherylSwanson published an article 4:31 PM

3 Great Dividend Stocks with a Clearance Sale Going on Now

These great stocks offer excellent yields, exceptional growth, and are terrific bargains.

Sun Nov 27

NL

Article

CherylSwanson published an article 6:59 PM

3 Biotechs With Save-the-Date Catalysts on Tap

Kite Pharma, bluebird bio, and ACADIA Pharmaceuticals all have price-shaking catalysts approaching that could bring big profits to investors.

Mon Nov 21

NL

Article

CherylSwanson published an article 1:06 PM

Why UnitedHealth Is the Only Healthcare Insurer to Own

With the Affordable Care Act's future in jeopardy, the insurance stock you want to own is the only one with zero exposure to the ACA: UnitedHealth.

Tue Nov 15

NL

Article

CherylSwanson published an article 11:18 AM

Is Pfizer Rethinking a Company Spin-Off?

A $14 billion spin-off of its over-the-counter drug unit would be great news for investors -- but will it happen?

Sun Nov 13

NL

Article

CherylSwanson published an article 6:25 PM

You'll Never Guess Who Owns the Most Spectacular New Cancer Drug

Johnson & Johnson's new cancer treatment isn't just a drug; it's a $5 billion breakthrough.

Sun Oct 30

NL

Article

CherylSwanson published an article 9:08 PM

3 Stocks Set to Thrive in Pharma's New Price-Conscious World

Worried about the election's impact on pharma? Protect yourself with three great stocks relying on innovation, not price increases, for growth

Tue Oct 25

NL

Article

CherylSwanson published an article 7:54 PM

$10 Billion Flop: Is Amgen Stock Still a Buy?

With Amgen facing declining demand for its blockbusters, as well as a key failure with its $10 billion pipeline molecule, is this biotech worth buying?

Sun Oct 23

NL

Article

CherylSwanson published an article 11:02 AM

No Cure Yet for Breast Cancer, but 3 Big Advances in 2016

Here’s how an exciting wave of recent discoveries is moving us closer to a cure.

Thu Oct 20

NL

Article

CherylSwanson published an article 3:18 PM

Unfazed by FDA Warning, Gilead Sciences' Stock Could Be Turning a Corner

Look past the scary headlines, and you may see a comeback in store for Gilead's investors.

Sat Oct 15

NL

Article

CherylSwanson published an article 7:42 AM

3 Cardiac-Care Stocks That Could Bring Heart-Stopping Gains

Investors hit the jackpot with cardiac-care stocks last year. Here are three stocks primed to continue the heart-stopping gains.

Wed Oct 12

NL

Article

CherylSwanson published an article 11:17 PM

7 Reasons Celgene Is the Best Bet in Biotech

Here’s how Celgene plans to rack up double-digit growth for decades to come.

Sun Oct 2

NL

Article

CherylSwanson published an article 7:14 PM

Tesaro Inc. Is Flying High Today (and Could Go Higher From Here)

Here's why cancer biotech Tesaro could be in the midst of a new lift-off.

Thu Sep 29

NL

Article

CherylSwanson published an article 7:08 PM

3 Reasons Pfizer's Recent Drop Could Make It a Buying Opportunity

This stock is back in the game with a pipeline full of near-term catalysts, superstar oncology drugs, and a 3.5% dividend yield.

Tue Sep 27

NL

Article

CherylSwanson published an article 12:02 AM

Is Celgene the Smartest Buyer in Biotech?

Celgene’s deal-making genius tilts the odds in favor of its investors.

Sun Sep 25

NL

Article

CherylSwanson published an article 10:00 PM

How Oncology Could Move the Needle for Johnson & Johnson's Stock

Johnson & Johnson has some oncology drug surprises up its sleeves that could drive further upside for this great stock.

Wed Sep 21

NL

Article

CherylSwanson published an article 6:21 PM

3 Biotechs With Potential Big-Time Upside

These three high-risk/high-reward biotechs have drugs in late-stage trials and key catalysts just around the corner.

Sun Sep 18

NL

Article

CherylSwanson published an article 5:47 PM

Why Johnson & Johnson's New Wearable for Diabetics Should Be a Home Run

Johnson & Johnson is launching a wearable that boldly embraces the huge diabetes market -- and could reignite its lagging medical-devices division.

Thu Sep 15

NL

Article

CherylSwanson published an article 6:41 PM

Juno Therapeutics and Kite Pharma: The Danger of Alarmingly Thin Data

The two biotechs are closing in on explosive potential catalysts, including FDA filings and hoped-for approvals, but thin data could bring nasty surprises for investors.

Tue Sep 13

NL

Article

CherylSwanson published an article 10:47 PM

Apple iPhone Calling Big Pharma: We Can Help You Develop Better Drugs

Apple is moving deeper into healthcare -- and big pharma is answering the call.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 74632
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 3
Total Picks 3
Best Pick EW (+31.14)
Worst Pick GILD (-58.09)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to CherylSwanson’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show CherylSwanson’s 10 Latest Posts